The healthcare data analytics software provider has now raised more than $31m in total, after BlueCross BlueShield Venture Partners and Intel Capital reinvested.
US-based predictive analytics technology developer Lumiata has raised $11m in a funding round co-led by BlueCross BlueShield Venture Partners, the corporate venturing representative of health insurer Blue Cross Blue Shield Association.
Venture capital firm Khosla Ventures co-led the round, which featured semiconductor technology producer Intel’s corporate venturing unit, Intel Capital, and VC firm Sandbox Industries, increasing Lumiata’s total funding to $31m.
Founded in 2013, Lumiata has developed an artificial intelligence-equipped data analytics platform for healthcare provision that models disease risk…
